Analyst consensus rating
Pharming Group Analyst Rating: none
PHAR is rated none by 4 analysts with a $34.35 target. As of 2026-08-22.
Direct answer
Pharming Group's consensus rating is none.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $34.35.
Forecast evidence checked August 22, 2026.
Get free Pharming Group email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $11.85
- Average price target
- $34.35
- High price target
- $39.00
- Low price target
- $23.40
- Low target gap
- +97.5%
- Target upside
- +189.9%
- High target gap
- +229.1%
- Target range width
- 131.6%
- Consensus rating
- none
- Analysts
- 4
- Evidence date
- August 22, 2026
- Valid through
- August 29, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Pharming Group?
Pharming Group has a verified none consensus. The same dataset has an average price target of $34.35.
How far are Pharming Group's low and high targets from the recorded price?
The low target implies +97.5%, while the high target implies +229.1%.
How many analysts are included in Pharming Group's consensus?
The verified consensus includes 4 analysts.
How is Pharming Group's target upside or downside calculated?
The average target of $34.35 is divided by the recorded price of $11.85, then one is subtracted to produce +189.9%. This does not guarantee a future return.
When was Pharming Group's analyst forecast verified?
The data was verified on 2026-08-22. The dataset is valid through 2026-08-29.